Why a cure for HIV remains elusive Paula Cevaal, Michael Roche and Sharon Lewin, The Peter Doherty Institute for Infection and Immunity Advances in cancer treatment, gene editing and mRNA technology are helping researchers in their pursuit of an HIV cure.
Video: What do people want out of HIV PrEP? Curtis Chan, Kirby Institute, UNSW A study has found that cost and access are the main barriers to more people using pre-exposure prophylaxis, or PrEP .
Eliminating HIV transmission is close, but we’re not there yet Skye McGregor and Darryl O’Donnell, Kirby Institute, UNSW Australia is getting close to eliminating HIV transmission, but inequities in the delivery and uptake of prevention and treatment strategies remain.
Why stigma remains the biggest challenge in the fight against HIV Elizabeth Armstrong-Mensah, Georgia State University HIV care and treatment have made huge advancements, but stigma remains a major obstacle.
With HIV PrEP, one size does not fit all Gilda Tachedjian, Burnet Institute and Monash University Access to a variety of PrEP methods allows women to choose what best suits them, depending on their context and where they are in their reproductive lifespan.
Key Facts:
All 360info content is licensed under Creative Commons 4.0, meaning you can: Share – copy and redistribute the material in any format Adapt – remix, transform and build upon the material for any purpose, even commercially.
All we ask is that our author bylines are retained – you are welcome to include your own – and 360info is referenced at the foot of an article i.e. “This article was originally published under Creative Commons by 360info”
About us:
About 360info
360info is a Not-For-Profit public interest journalism initiative. Editorial focus is on big-picture global issues, rather than breaking news. A team of professional journalists and editors commission university-affiliated academics around the world to write features, explainers & contextual pieces, then translate their work into plain, understandable language.
